CROI 2019 Program and Conference Information

Oral Sessions

Conveners Thomas Schulz, Medizinischen Hochschule Hannover, Hannover, Germany Jianxin You, University of Pennsylvania, Philadelphia, PA, USA 55

MODULATION OF HOST INNATE IMMUNITY BY KSHV Blossom Damania, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA EBV: IMMUNOPATHOGENESIS AND THE PATH TO AN EBV VACCINE Jeffrey Cohen, NIAID, Bethesda, MD, USA HPV: NEW INSIGHTS INTO ONCOGENESIS AND OPPORTUNITIES FOR IMMUNE CONTROL Denise Galloway, Fred Hutchinson Cancer Research Center, Seattle, WA, USA HBV: FROMVIRAL INTEGRATION TO LIVER CANCER, IMPACT ON CURE STRATEGIES Fabien Zoulim, INSERM, Strasbourg, France

4:00

56 4:30

57 5:00

58 5:30

Symposium S-2 ART AND REPRODUCTION Room 6E 4:00 PM - 6:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in understanding the current state of knowledge regarding the use of antiretroviral therapy in women of reproductive potential and the potential impacts of antiretrovirals on maternal health and pregnancy outcomes. Level of Knowledge: It is assumed that the participants have familiarity with issues of HIV treatment and prevention of mother-to-child transmission, as well as basic understandings of the processes of conception, gestation and delivery. Objectives: At the completion of the session, participants will be able to: • Describe the existing evidence for associations between contemporary ARVs and birth defects in the context of state-of-art HIV treatment • Elucidate issues facing clinicians, policymakers, and researchers related to this topic Conveners CME

Oral Sessions • Tuesday

Tendayi Westerhof, Pan African Positive Women's Coalition-Zimbabwe, Kadoma, Mashonaland West Province, Zimbabwe Meg Doherty, WHO, Geneva, Switzerland 59

UPDATE ON ANTIRETROVIRAL DRUGS AND BIRTH DEFECTS Lynne M. Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA ART OPTIONS AND TREATMENT DECISIONS FOR WOMEN OF REPRODUCTIVE POTENTIAL Monica Gandhi, University of California San Francisco, San Francisco, CA, USA

4:00

60 4:30

CROI 2019 40